An essential aspect of APIs is their role in generic medications. When the patent for a branded drug expires, other companies can produce generic versions of the drug using the same API, often at a lower cost. This process promotes competition in the pharmaceutical market, ultimately benefiting consumers by providing more affordable medication options. However, regulatory standards still apply to generic drugs, ensuring that they are equivalent in safety and efficacy to their branded counterparts.
Isoflurane is a widely used inhalational anesthetic that has gained prominence in both human and veterinary medicine. As a halogenated ether, isoflurane offers several advantages, including a rapid onset and offset of action, making it suitable for various surgical procedures and outpatient surgeries.
Moreover, the COVID-19 pandemic highlighted the vulnerabilities in the global API supply chain. It underscored the importance of securing local supply chains and investing in domestic production capabilities. As a result, there is a growing trend toward nearshoring and investment in local API manufacturing facilities to reduce dependency on foreign sources.